AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

We recently compiled a list of the 10 Best UK Stocks to Invest in ... and Imfinzi as key differentiators. AstraZeneca PLC ...

Ozempic and Wegovy, made by Novo Nordisk, are now listed as available across all doses on the FDA’s drug shortage list. But ...

Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

AstraZeneca Plc said its experimental obesity ... in nausea and vomiting,” as can be expected with this type of drug, said Sharon Barr, executive vice-president of biopharmaceuticals R&D.

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge ...

AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former ...

The investigation focuses on potential breaches of data privacy laws and the importation of unlicensed cancer medications. CEO Pascal Soriot said AstraZeneca complies with Chinese policies and ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...